Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Nienke A de Glas"'
Autor:
Hans Gelderblom, Marta Fiocco, Simon P Mooijaart, Gerrit-Jan Liefers, Wilbert B van den Hout, Frank M Speetjens, Frederiek van den Bos, Leti van Bodegom-Vos, Marije Slingerland, Nienke A de Glas, Johanneke E A Portielje, Marissa Cloos-van Balen, Joosje C Baltussen, Trishika R R Binda, Arjan J Verschoor, Cynthia Holterhues, Danny Houtsma, Anouk Jochems, Leontine E A M M Spierings
Publikováno v:
BMJ Open, Vol 14, Iss 8 (2024)
Introduction Treating older adults with chemotherapy remains a challenge, given their under-representation in clinical trials and the lack of robust treatment guidelines for this population. Moreover, older patients, especially those with frailty, ha
Externí odkaz:
https://doaj.org/article/cc10accdfbcd4ad6ba94b0ed10167cff
Publikováno v:
The Lancet. Healthy Longevity, Vol 1, Iss 1, Pp e43-e47 (2020)
Summary: Studies on new anticancer drugs often inappropriately conclude that these treatments are well tolerated and feasible in the older population with cancer, despite the drug being investigated in only a selection of healthy older patients who a
Externí odkaz:
https://doaj.org/article/c743591ae4014ee59ef977e2ea1be27b
Autor:
Joosje C. Baltussen, Marloes G.M. Derks, Annelieke A. Lemij, Nienke A. de Glas, Marta Fiocco, Eugenie M.H. Linthorst-Niers, Annelie J.E. Vulink, Leander van Gerven, Onno R. Guicherit, Thijs van Dalen, Jos W.S. Merkus, Titia E. Lans, Carmen C. van der Pol, Simon P. Mooijaart, Johanneke E.A. Portielje, Gerrit-Jan Liefers
Publikováno v:
European Journal of Cancer. 185:1-10
Autor:
Annelieke A Lemij, Gerrit Jan Liefers, Marloes G M Derks, Esther Bastiaannet, Marta Fiocco, Titia E Lans, Carmen C van der Pol, Annelie J E Vulink, Leander van Gerven, Onno R Guicherit, Eugenie M H Linthorst-Niers, Jos W S Merkus, Thijs van Dalen, Johanneke E A Portielje, Nienke A de Glas
Publikováno v:
The Oncologist.
BackgroundA decline in physical activity and the ability to perform activities of daily living (ADL) and instrumental activities of daily living (IADL) could interfere with independent living and quality of life in older patients, but may be prevente
Autor:
Annelieke A. Lemij, Nienke A. de Glas, Marloes G. M. Derks, Esther Bastiaannet, Jos W. S. Merkus, Titia E. Lans, Carmen C. van der Pol, Thijs van Dalen, Annelie J. E. Vulink, Leander van Gerven, Onno R. Guicherit, Eugenie M. H. Linthorst-Niers, Frederiek van den Bos, Judith R. Kroep, Gerrit Jan Liefers, Johanneke E. A. Portielje
Publikováno v:
Breast Cancer Research and Treatment, 193, 567-577. SPRINGER
Breast cancer research and treatment, 193(3), 567-577. Springer New York
Breast cancer research and treatment, 193(3), 567-577. Springer New York
Purpose Side effects are the main reason for discontinuation of adjuvant endocrine therapy in older adults. The aim of this study was to examine geriatric predictors of treatment discontinuation of adjuvant endocrine therapy within the first 2 years
Autor:
Yara van Holstein, Stella Trompet, Floor J. van Deudekom, Barbara van Munster, Nienke A. de Glas, Frederiek van den Bos, Anna Uit den Boogaard, Marjan J. T. van der Elst, Marleen A. E. van der Kaaij, Karen J. Neelis, Alexandra M. J. Langers, Marije Slingerland, Johanneke E. A. Portielje, Simon P. Mooijaart
Publikováno v:
ACTA ONCOLOGICA, 459-467. Taylor & Francis Ltd
STARTPAGE=459;ENDPAGE=467;ISSN=0284-186X;TITLE=ACTA ONCOLOGICA
Acta Oncologica, 61(4), 459-467. TAYLOR & FRANCIS LTD
STARTPAGE=459;ENDPAGE=467;ISSN=0284-186X;TITLE=ACTA ONCOLOGICA
Acta Oncologica, 61(4), 459-467. TAYLOR & FRANCIS LTD
Background Patients with potentially curable esophageal cancer can be treated with neo-adjuvant chemoradiotherapy followed by surgery or definitive chemoradiotherapy with curative intent. For frail older patients choosing the appropriate oncological
Autor:
Willeke G. van der Plas-Krijgsman, Jenna L. Morgan, Nienke A. de Glas, Anna Z. de Boer, Charlene L. Martin, Geoffrey R. Holmes, Susan E. Ward, Tim Chater, Malcolm W. Reed, Jos W.S. Merkus, Thijs van Dalen, Annelie J.E. Vulink, Leander van Gerven, Onno R. Guicherit, Eugenie Linthorst-Niers, Titia E. Lans, Esther Bastiaannet, Johanneke E.A. Portielje, Gerrit Jan Liefers, Lynda Wyld
Publikováno v:
European Journal of Cancer, 163, 189-199. ELSEVIER SCI LTD
Background: Previous studies have shown that survival outcomes for older patients with breast cancer vary substantially across Europe, with worse survival reported in the United Kingdom. It has been hypothesised that these differences in survival out
Autor:
M.E.C. Waaijer, A.A. Lemij, A.Z. de Boer, E. Bastiaannet, F. van den Bos, M.G.M. Derks, J.R. Kroep, G.J. Liefers, J.E.A. Portielje, Nienke Aafke de Glas
Introduction In recent years, primary surgical treatment of older women with non-metastatic breast cancer has decreased in favor of primary endocrine therapy (PET). PET can be considered in women with a remaining life expectancy of less than five yea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ce663e25d7933e3f421ef09c62c35101
https://doi.org/10.21203/rs.3.rs-2354216/v1
https://doi.org/10.21203/rs.3.rs-2354216/v1
Autor:
Annelieke A. Lemij, Nienke A. de Glas, Marloes G.M. Derks, Eugenie M.H. Linthorst-Niers, Onno R. Guicherit, Carmen C. van der Pol, Titia E. Lans, Thijs van Dalen, Annelie J.E. Vulink, Jos W.S. Merkus, Leander van Gerven, Frederiek van den Bos, Nathaly Rius Ottenheim, Gerrit-Jan Liefers, Johanneke E.A. Portielje
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e8f32ef42cb5cdaecaf95ead53bdb73
https://doi.org/10.2139/ssrn.4367385
https://doi.org/10.2139/ssrn.4367385
Autor:
Anna Z. de Boer, Esther Bastiaannet, Johannes Schetelig, Nienke A. de Glas, Damjan Manevksi, Hein Putter, Gerrit Jan Liefers, Linda de Munck, Johanneke E.A. Portielje, Liesbeth C. de Wreede
Publikováno v:
European Journal of Cancer, 174, 212-220. ELSEVIER SCI LTD
Introduction: In older patients with breast cancer, the risk of dying from other causes than breast cancer strongly increases after the age of 70. The aim of this study was to assess contributions of breast cancer mortality versus other-cause mortali
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c7039c916034f897c4a80f786159693
https://hdl.handle.net/1887/3564245
https://hdl.handle.net/1887/3564245